Biotech Stocks To Buy Based on Pattern Recognition: Returns up to 383.54% in 1 Year

Biotech Stocks To Buy

The BioTech Stocks Package is designed for investors and analysts who need predictions of the best biotech stocks to buy for the whole Biotechnology Industry. It includes 20 stocks with bullish and bearish signals and indicates the best biotech stocks to trade:

  • Top 10 Biotech stocks for the long position
  • Top 10 Biotech stocks for the short position

BioTech Stocks
Package Name: BioTech Stocks
Recommended Positions: Long
Forecast Length: 1 Year (03/21/2017 – 03/21/2018)
I Know First Average: 86.70%
Biotech Stocks To Buy

Several predictions in this long-term 1 Year forecast saw significant returns. The algorithm had correctly predicted 5 out 10 stock movements. NKTR was the top performing prediction with a return of 383.54%. IMGN and DVAX saw outstanding returns of 241.53% and 206.67%. With these notable trade returns, the package itself registered an average return of 86.70% compared to the S&P 500’s return of 14.26% for the same period.

Nektar Therapeutics (NKTR), develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. Its product pipeline includes drug candidates in therapeutic areas comprising cancer, auto-immune disease, and chronic pain.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.